Technical Analysis for BIOC - Biocept, Inc.

Grade Last Price % Change Price Change
grade F 0.92 6.79% 0.06
BIOC closed up 6.79 percent on Friday, September 13, 2019, on 2.62 times normal volume.

Earnings due: Sep 27

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Up
See historical BIOC trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Crossed Above 20 DMA Bullish 0.00%
MACD Bullish Signal Line Cross Bullish 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Outside Day Range Expansion 0.00%
180 Bearish Setup Bearish Swing Setup 6.79%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 6.79%
Oversold Stochastic Weakness 6.79%
Narrow Range Bar Range Contraction 4.58%
Oversold Stochastic Weakness 4.58%

Older signals for BIOC ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Biocept, Inc., a cancer diagnostics company, is engaged in the development and commercialization of proprietary circulating tumor cell (CTC) and circulating tumor DNA tests. The company's tests provide information to oncologists that enable them to select the appropriate treatment for their patients based on detailed data on the characteristics of tumors. Its tests include OncoCEE-BR, a breast cancer CTC test that allows physician to characterize the tumor to help define treatment options. The company sells its products through its sales force and partners that focus on selling directly to community oncologists in hospitals, cancer centers, and offices in the United States. Biocept, Inc. was founded in 1997 and is headquartered in San Diego, California.
Medicine Cancer Medical Specialties Clinical Medicine Oncology Tumor Tumors Anatomical Pathology
Is BIOC a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 3.72
52 Week Low 0.66
Average Volume 445,901
200-Day Moving Average 1.1128
50-Day Moving Average 0.9781
20-Day Moving Average 0.9065
10-Day Moving Average 0.875
Average True Range 0.0451
ADX 21.4
+DI 20.092
-DI 19.8541
Chandelier Exit (Long, 3 ATRs ) 0.9147
Chandelier Exit (Short, 3 ATRs ) 0.9653
Upper Bollinger Band 0.9883
Lower Bollinger Band 0.8247
Percent B (%b) 0.58
BandWidth 18.047435
MACD Line -0.032
MACD Signal Line -0.0358
MACD Histogram 0.0039
Fundamentals Value
Market Cap 27.84 Million
Num Shares 30.3 Million
EPS -1.06
Price-to-Earnings (P/E) Ratio -0.87
Price-to-Sales 5.54
Price-to-Book 3.79
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.04
Resistance 3 (R3) 1.03 0.99 1.02
Resistance 2 (R2) 0.99 0.96 0.99 1.01
Resistance 1 (R1) 0.95 0.94 0.97 0.96 1.01
Pivot Point 0.91 0.91 0.92 0.91 0.91
Support 1 (S1) 0.87 0.88 0.89 0.88 0.83
Support 2 (S2) 0.83 0.86 0.83 0.83
Support 3 (S3) 0.79 0.83 0.82
Support 4 (S4) 0.80